NIPER Hajipur Signs MoU with Boehringer Ingelheim

In line with the growing emphasis on strengthening industry–academia partnerships to drive innovation and translational research in India’s pharmaceutical sector, the National Institute of Pharmaceutical Education and Research (NIPER) Hajipur has signed a Memorandum of Understanding (MoU) with Boehringer Ingelheim India Pvt. Ltd., marking a significant step towards fostering collaborative research and accelerating healthcare solutions. The MoU was signed in the presence of Manoj Joshi, Secretary, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers at Kartavya Bhawan in New Delhi.

The collaboration between NIPER Hajipur and Boehringer Ingelheim is expected to foster synergy between academia and industry and contribute to the development of next-generation therapies and support the broader objective of building a robust, innovation-driven healthcare ecosystem in the country.(UPDATED ON 24TH APRIL 2026)